Research & Development

Enhanced Biopharma Efficiency with Raman Spectroscopy
Research & Development Enhanced Biopharma Efficiency with Raman Spectroscopy

The biopharmaceutical industry is rapidly evolving, fueled by cutting-edge technologies and scientific breakthroughs. Novel treatments such as cell and gene therapies, biologics, and vaccines are reaching the market at unprecedented speeds. However, the rigorous journey from drug development to

Can BB-301 Gene Therapy Revolutionize Treatment for OPMD Patients?
Research & Development Can BB-301 Gene Therapy Revolutionize Treatment for OPMD Patients?

Oculopharyngeal Muscular Dystrophy (OPMD) is a rare, progressive muscle-wasting disease that significantly impacts patients' quality of life. Limited therapeutic options are available, with current treatments failing to address the underlying muscle weakness driving the disease's

Boehringer and Circle Partner on Precision Cancer Therapy Innovation
Research & Development Boehringer and Circle Partner on Precision Cancer Therapy Innovation

In an ambitious endeavor to revolutionize cancer treatment, Boehringer Ingelheim and Circle Pharma have entered into a research partnership and license agreement aimed at developing a first-in-class cyclin inhibitor. This groundbreaking collaboration is set to provide novel treatment options for

How Do Regulatory Experts Shape Biotech and Cell Therapy Innovation?
Research & Development How Do Regulatory Experts Shape Biotech and Cell Therapy Innovation?

Innovation in biotechnology, particularly within the realm of cell therapy, hinges significantly on the expertise of regulatory professionals. These experts are instrumental in navigating complex regulatory landscapes and ensuring that scientific advances transition into viable, market-ready

Kiromic BioPharma's Deltacel Shows Promise in Advanced NSCLC Trial
Research & Development Kiromic BioPharma's Deltacel Shows Promise in Advanced NSCLC Trial

The landscape of cancer treatment is ever-evolving, with new therapies continually pushing the boundaries of what is possible. Kiromic BioPharma's latest advancement, Deltacel, an allogeneic gamma delta T-cell (GDT) therapy, is showing significant promise in the treatment of advanced non-small

Scholar Rock's Apitegromab Advances SMA Treatment with Phase 3 Success
Research & Development Scholar Rock's Apitegromab Advances SMA Treatment with Phase 3 Success

The field of spinal muscular atrophy (SMA) treatment has been dynamically evolving, and the latest breakthrough stems from Scholar Rock's Phase 3 clinical trial of apitegromab. This experimental drug is designed to preserve muscle function, representing a potential new standard of care for SMA

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later